Showing results (41-50 of 69) with videos related to
Sort By:
Pageof 7
Pharmaceuticals (Basel, Switzerland)|September 28, 2021
Privileged Quinolylnitrones for the Combined Therapy of Ischemic Stroke and Alzheimer's DiseaseJosé M Alonso, Alejandro Escobar-Peso, Alejandra Palomino-Antolín, et al.Journal of Medicinal Chemistry|July 4, 2018
Contilisant, a Tetratarget Small Molecule for Alzheimer's Disease Therapy Combining Cholinesterase, Monoamine Oxidase Inhibition, and H3R Antagonism with S1R Agonism ProfileÓscar M Bautista-Aguilera, Josiane Budni, Francielle Mina, et al.European Journal of Medicinal Chemistry|April 17, 2012
Multipotent MAO and cholinesterase inhibitors for the treatment of Alzheimer's disease: synthesis, pharmacological analysis and molecular modeling of heterocyclic substituted alkyl and cycloalkyl propargyl amineAbdelouahid Samadi, Cristóbal de los Ríos, Irene Bolea, et al.Molecules (Basel, Switzerland)|April 20, 2019
QuinoxalineTacrine QT78, a Cholinesterase Inhibitor as a Potential Ligand for Alzheimer's Disease TherapyEva Ramos, Alejandra Palomino-Antolín, Manuela Bartolini, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|February 5, 2019
Donepezil + chromone + melatonin hybrids as promising agents for Alzheimer's disease therapyIrene Pachón-Angona, Bernard Refouvelet, Rudolf Andrýs, et al.Journal of Medicinal Chemistry|June 26, 2010
Synthesis, inhibitory activity of cholinesterases, and neuroprotective profile of novel 1,8-naphthyridine derivativesCristóbal de Los Ríos, Javier Egea, José Marco-Contelles, et al.International Journal of Molecular Sciences|June 10, 2023
Exploring the Potential of Sulfonamide-Dihydropyridine Hybrids as Multitargeted Ligands for Alzheimer's Disease TreatmentImen Dakhlaoui, Paul J Bernard, Diana Pietrzak, et al.European Journal of Medicinal Chemistry|October 18, 2011
Synthesis and biological assessment of diversely substituted furo[2,3-b]quinolin-4-amine and pyrrolo[2,3-b]quinolin-4-amine derivatives, as novel tacrine analoguesCarla Martins, M Carmo Carreiras, Rafael León, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|November 29, 2018
Synthesis and biological assessment of KojoTacrines as new agents for Alzheimer's disease therapyYoussef Dgachi, Hélène Martin, Rim Malek, et al.Biochemical Pharmacology|May 8, 2013
Propafenone blocks human cardiac Kir2.x channels by decreasing the negative electrostatic charge in the cytoplasmic poreIrene Amorós, Pablo Dolz-Gaitón, Ricardo Gómez, et al.Pageof 7